(WASHINGTON)Federal regulators warned doctors Tuesday about severe skin reactions seen in patients taking an injectable treatment for alcoholism made by Alkermes Inc. and marketed by Cephalon ...READ MORE

(WASHINGTON)Biotech drugmaker Cephalon spent nearly $516,000 lobbying the federal government in the second quarter, according to a recent disclosure form. The Frazer, Pa.-based company lobbied...READ MORE

Among the earnings projection stories for Tuesday, July 29, from AP Financial News: FRAZER, Pa. (AP)--Biotechnology company Cephalon Inc. on Tuesday raised its outlook for the full...READ MORE

Among the earnings stories for Tuesday, July 29, from AP Financial News: Top stories:READ MORE

(FRAZER, Pa.)Biotechnology company Cephalon Inc. on Tuesday raised its outlook for the full fiscal year after posting second-quarter profit results that beat Wall Street expectations.READ MORE

(FRAZER, Pa.)Biotechnology company Cephalon Inc. said Tuesday it swung to a profit in the second quarter, helped by brisk sales of central nervous system drugs and of new drugs it didn't offer ...READ MORE

(NEW YORK)AutoGenomics Inc., which makes diagnostic systems that test for genetic and infectious diseases and cancer, is planning an initial public offering of common stock, according to a S...READ MORE